Abbott, Baxter, Bristol-Myers Squibb: Emerging Markets Earnings Roundup (Part 1 of 3)

A push in emerging markets continued in the second quarter with Big Pharma reporting flat U.S. sales and a challenging payer environment in Europe, with many reallocating resources in Asia and forming more Asia partnerships. As a recurring feature, PharmAsia News combs through quarterly earnings reports to bring together the earning season's Asia highlights.